Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Proprotein convertase subtilisin/kexin type 9 and lipid metabolism.

Spolitu S, Dai W, Zadroga JA, Ozcan L.

Curr Opin Lipidol. 2019 Jun;30(3):186-191. doi: 10.1097/MOL.0000000000000601.

PMID:
30925519
2.

Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein Cholesterol.

Spolitu S, Okamoto H, Dai W, Zadroga JA, Wittchen ES, Gromada J, Ozcan L.

Circ Res. 2019 Jan 4;124(1):38-51. doi: 10.1161/CIRCRESAHA.118.313648.

PMID:
30582457
3.

Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease models.

Lecca D, Janda E, Mulas G, Diana A, Martino C, Angius F, Spolitu S, Casu MA, Simbula G, Boi L, Batetta B, Spiga S, Carta AR.

Br J Pharmacol. 2018 Aug;175(16):3298-3314. doi: 10.1111/bph.14214. Epub 2018 Jul 12.

PMID:
29570770
4.

Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease.

Mulas G, Espa E, Fenu S, Spiga S, Cossu G, Pillai E, Carboni E, Simbula G, Jadžić D, Angius F, Spolitu S, Batetta B, Lecca D, Giuffrida A, Carta AR.

Exp Neurol. 2016 Dec;286:83-92. doi: 10.1016/j.expneurol.2016.09.013. Epub 2016 Sep 30.

PMID:
27697481
5.

Multidrug resistance P-glycoprotein dampens SR-BI cholesteryl ester uptake from high density lipoproteins in human leukemia cells.

Spolitu S, Uda S, Deligia S, Frau A, Collu M, Angius F, Batetta B.

Am J Cancer Res. 2016 Feb 15;6(3):615-27. eCollection 2016.

6.

High-density lipoprotein contribute to G0-G1/S transition in Swiss NIH/3T3 fibroblasts.

Angius F, Spolitu S, Uda S, Deligia S, Frau A, Banni S, Collu M, Accossu S, Madeddu C, Serpe R, Batetta B.

Sci Rep. 2015 Dec 7;5:17812. doi: 10.1038/srep17812.

7.

Neutral lipid alterations in human herpesvirus 8-infected HUVEC cells and their possible involvement in neo-angiogenesis.

Angius F, Uda S, Piras E, Spolitu S, Ingianni A, Batetta B, Pompei R.

BMC Microbiol. 2015 Mar 28;15:74. doi: 10.1186/s12866-015-0415-7.

8.

Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.

Fredman G, Kamaly N, Spolitu S, Milton J, Ghorpade D, Chiasson R, Kuriakose G, Perretti M, Farokzhad O, Tabas I.

Sci Transl Med. 2015 Feb 18;7(275):275ra20. doi: 10.1126/scitranslmed.aaa1065. Erratum in: Sci Transl Med. 2015 Mar 4;7(277):277er2. Farokzhad, Omid [corrected to Farokhzad, Omid].

9.

Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway.

Fredman G, Ozcan L, Spolitu S, Hellmann J, Spite M, Backs J, Tabas I.

Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14530-5. doi: 10.1073/pnas.1410851111. Epub 2014 Sep 22.

10.

Role of HDL in cholesteryl ester metabolism of lipopolysaccharide-activated P388D1 macrophages.

Uda S, Spolitu S, Angius F, Collu M, Accossu S, Banni S, Murru E, Sanna F, Batetta B.

J Lipid Res. 2013 Nov;54(11):3158-69. doi: 10.1194/jlr.M042663. Epub 2013 Aug 16.

11.

A lipoprotein source of cholesteryl esters is essential for proliferation of CEM-CCRF lymphoblastic cell line.

Uda S, Accossu S, Spolitu S, Collu M, Angius F, Sanna F, Banni S, Vacca C, Murru E, Mulas C, Diaz G, Batetta B.

Tumour Biol. 2012 Apr;33(2):443-53. doi: 10.1007/s13277-011-0270-6. Epub 2011 Dec 10.

PMID:
22161086

Supplemental Content

Loading ...
Support Center